- ZYUS Life Sciences Receives Cannabis Drug License from Health Canada
- INSERTING and REPLACING ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9
- ZYUS Announces Completion of Its Annual Filings
- ZYUS Announces Anticipated Delay in Its Annual Filings
- ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management
More ▼
Key statistics
On Thursday, ZYUS Life Sciences Corp (ZYUS:CVE) closed at 1.05, 47.89% above the 52 week low of 0.71 set on Nov 29, 2023.
52-week range
Open | 1.09 |
---|---|
High | 1.10 |
Low | 1.05 |
Bid | 1.03 |
Offer | 1.08 |
Previous close | 1.05 |
Average volume | 2.16k |
---|---|
Shares outstanding | 70.85m |
Free float | 32.69m |
P/E (TTM) | -- |
Market cap | 74.67m CAD |
EPS (TTM) | -0.5751 CAD |
Data delayed at least 15 minutes, as of Jun 06 2024 16:57 BST.
More ▼